Evidence map›Paper›PMID 25822541›Full record

ArticlePloS one2015

Germline-transmitted genome editing in Arabidopsis thaliana Using TAL-effector-nucleases.

Joachim Forner, Anne Pfeiffer, Tobias Langenecker, Pablo A Manavella, Pablo Manavella, Jan U Lohmann

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Joachim FornerCentre for Organismal Studies, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.
Anne PfeifferCentre for Organismal Studies, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.
Tobias LangeneckerDepartment of Molecular Biology, Max Planck Institute for Developmental Biology, Tübingen, Baden-Württemberg, Germany.
Pablo A Manavella
Pablo ManavellaDepartment of Molecular Biology, Max Planck Institute for Developmental Biology, Tübingen, Baden-Württemberg, Germany.
Jan U LohmannCentre for Organismal Studies, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcription activator-like effector nucleases (TALENs) are custom-made bi-partite endonucleases that have recently been developed and applied for genome engineering in a wide variety of organisms. However, they have been only scarcely used in plants, especially for germline-modification. Here we report the efficient creation of small, germline-transmitted deletions in Arabidopsis thaliana via TALENs that were delivered by stably integrated transgenes. Using meristem specific promoters to drive expression of two TALEN arms directed at the CLV3 coding sequence, we observed very high phenotype frequencies in the T2 generation. In some instances, full CLV3 loss-of-function was already observed in the T1 generation, suggesting that transgenic delivery of TALENs can cause highly efficient genome modification. In contrast, constitutive TALEN expression in the shoot apical meristem (SAM) did not cause additional phenotypes and genome re-sequencing confirmed little off-target effects, demonstrating exquisite target specificity.

Indexed as

ArabidopsisArabidopsis ProteinsBase SequenceDNA Restriction EnzymesGene TargetingGenetic EngineeringGerm-Line MutationMolecular Sequence DataPlasmidsSequence Analysis, DNATransgenesArabidopsis ProteinsAT2G27250 protein, ArabidopsisDNA Restriction Enzymes

Identifiers

PMID25822541
PMCPMC4378910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.